Document is current
Any future updates will be listed below
-
Authors
Ling, Xiaoxi
Latoche, Joseph D.
Choy, Cindy J.
Kurland, Brenda F.
Laymon, Charles M.
Wu, Yijen
Salamacha, Nathan
Shen, Ding
Geruntho, Jonathan J.
Rigatti, Lora H.
Windish, Hillarie P.
Langton-Webster, Beatrice
Berkman, Clifford E.
Anderson, Carolyn J. https://orcid.org/0000-0002-5663-282X
-
Funding
Funding for this research was provided by:
National Cancer Institute (HHSN261201500074C, P30 CA047904)
- License Information
-
More Information
Article History
First Online: 18 July 2019
Compliance with Ethical Standards
: Experiments on laboratory animals were performed in accordance with and approved by the University of Pittsburgh Institutional Animal Care and Use Committee (IACUC). All applicable institutional and/or national guidelines for the care and use of animals were followed.
: CJA is on the Scientific Advisory Board of Lumiphore (Berkeley, CA). XL, HW, and BLW are currently employees of CTT. CEB serves as a consultant to Cancer Targeted Technology and is the inventor of the CTT140X agents and the CTT1298 PSMA-inhibitor scaffold.
